Search results Altri temi

Empa is one of the partners who established the new “Dynamic Imaging Center” (DIC) in Bern.

sitem-insel has inaugurated the Dynamic Imaging Center, a groundbreaking facility that introduces a novel approach to X-ray imaging.

Philochem und Blue Earth Diagnostics haben im November im Nationalen Krebsinstitut von Mailand die ersten drei Patienten untersucht. Bild: Wikimedia / Gia.cossa

Philochem und Blue Earth Diagnostics haben in ihrer Phase-1-Studie die ersten drei Patienten untersucht. Die Studie dient der Entwicklung eines k...

Empa est l’un des partenaires qui ont mis en place le nouveau « Dynamic Imaging Center » (DIC) à Berne.

sitem-insel a inauguré le « Dynamic Imaging Center », une installation révolutionnaire qui propose une nouvelle approche de l'imagerie par rayons...

Philochem and Blue Earth Diagnostics have examined their first three patients in November at the National Cancer Institute of Milan, Italy. Image credit: Wikimedia / Gia.cossa

Philochem and Blue Earth Diagnostics have examined their first three patients as part of a Phase 1 clinical trial. The trial aims to develop a sm...

The inclusion of Aktiia’s technology in the GAPP study is a testament to its potential in reshaping blood pressure research.

Neuchâtel start-up Aktiia, a pioneer in cuffless blood pressure monitoring, has embarked on a groundbreaking study in collaboration with eminent ...

L’inclusion de la technologie d’Aktiia dans l’étude GAPP témoigne de son potentiel à remodeler la recherche sur la tension artérielle.

La start-up neuchâteloise Aktiia, pionnière de la surveillance de la pression artérielle sans brassard, s’est lancée dans une étude inédite en co...

De gauche à droite, Christoph Ammann, canton de Berne – Dr. med. h.c. Uwe E. Jocham, Insel Gruppe – Prof. Dr. Christian Leumann, Université de Berne – Dr. Alexandre Pauchard, CSEM, Jens Krauss, CSEM.

Le canton de Berne s’est donné pour mission de devenir un centre médical mondial de premier plan d’ici à 2030. En rassemblant une expertise médic...

From left to right: Christoph Ammann, Canton of Bern – Dr. med. h.c. Uwe E. Jocham, Insel Gruppe – Prof. Dr. Christian Leumann, University of Bern – Dr. Alexandre Pauchard, CSEM, Jens Krauss, CSEM.

The canton of Bern is on a mission to become a leading global medical hub by 2030. By combining an exceptional medical expertise medical expertis...

Thomas Ingold, CEO and Founder of DroneControl Sàrl.

Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.

La technologie de Novochizol transforme quantitativement des molécules linéaires de chitosan en nanosphères réticulées de taille uniforme.

Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...

Thomas Ingold, CEO et fondateur de DroneControl Sàrl.

Le FIF a soutenu quatre start-ups prometteuses pour favoriser l’innovation dans le cadre des Objectifs de Développement Durable de l’ONU.

The third building of the site was inaugurated in the presence (from left to right) of Stéphane Coppey, the President of the City of Monthey, Christophe Darbellay, Head of the Department of Economy and Education, and Jean-Marc Tornare, President of BioArk.

With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.

Novochizol technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres.

A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...

CDMOs play a crucial role in the pharmaceutical sector, serving as key partners in the drug development and production process.

Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...

montagne di rifiuti

La Nigeria è uno dei Paesi più inquinati al mondo. Tanto che le risorse e i mezzi di sussistenza sono a rischio. Tuttavia, l’enorme volume di rif...

Through this partnership, the synergy between academic excellence and pioneering biotherapeutic research is set to delineate new horizons in patient care, particularly in the field of tissue regeneration and repair.

Dans le but de redéfinir la médecine régénérative, l'Université Monash collabore avec la société valaisanne Orio Therapeutics pour innover dans l...

Through this partnership, the synergy between academic excellence and pioneering biotherapeutic research is set to delineate new horizons in patient care, particularly in the field of tissue regeneration and repair.

In a stride towards redefining regenerative medicine, Monash University collaborates with Valais-based Orio Therapeutics to innovate in the realm...

Adiposs pioneers a new era in cancer patient care with a pivotal leap towards making ImageBAT a revolutionary tool in detecting hypermetabolism.

Geneva-based biotech Adiposs casts a ray of hope onto the horizons of cancer treatment and patient care with the successful conclusion of the Pha...

Programma ufficiale

Export
Invest

Daniel Bangser

Investment Promotion Switzerland